Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study

Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study (COMPARE)

Retrospective, multicenter, comparative, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Renal Disease or Acute Kidney Injury.

Inclusion Criteria:

• Participant is 18 years of age.
• Participant weighs ≥ 34kg.
• Participant was hospitalized and had dialysis dependent End-Stage Renal Disease or Acute Kidney Injury and was prescribed acute intermittent renal replacement therapy.

Exclusion Criteria:

• Treatments isolated to ultrafiltration only.
• Any documented condition the Physician feels would prevent the participant from successful inclusion in the study.